Clinical Trial Update: Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating ipatasertib or apitolisib with abiraterone acetate versus abiraterone alone in previously treated castration-resistant prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• apitolisib (apitolisib)
• ipatasertib (ipatasertib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-14